Correlation of Pretransplant and Early Post-Transplant Response Assessment With Outcomes After Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma

BACKGROUND: Chemotherapy sensitivity, defined simply as at least a partial response to chemotherapy, is an important outcome predictor for non-Hodgkin lymphoma (NHL) patients undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (allo-HCT). The authors hypothesized that fur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Bishop, Michael R., Dean, Robert M., Steinberg, Seth M., Odom, Jeanne, Pollack, Seth M., Pavletic, Steven Z., Sportes, Claude, Gress, Ronald E., Fowler, Daniel H.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6582966/
https://ncbi.nlm.nih.gov/pubmed/20041482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24845
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares